However, a recent paper on pediatric Alport patients by Li et al. (20) demonstrated that at any age, and irrespective of the presence of proteinuria of kidney function, children with Alport syndrome (not treated with ACE inhibition) display a significantly lower uCreat than healthy controls. This evidence concerns the gene ACE and Alport syndrome.